Treatment of Gastric Epithelial Dysplasia That Is Diagnosed by Endoscopic Biopsy.
10.5230/jkgca.2010.10.1.1
- Author:
Eun Young KIM
1
;
Jin Jo KIM
;
Byung Wuk KIM
;
Seung Man PARK
Author Information
1. Department of Surgery, Incheon St. Mary's Hospital, The Catholic University of Korea, School of Medicine, Incheon, Korea. parksm@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Gastric epithelial dysplasia;
Gastric adenocarcinoma;
Endoscopic mucosal resection;
Endoscopic submucosal dissection
- MeSH:
Adenocarcinoma;
Biopsy;
Epithelium;
Humans;
Stomach
- From:Journal of the Korean Gastric Cancer Association
2010;10(1):1-4
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Gastric epithelial dysplasia (GED) was defined as "unequivocally neoplastic epithelium that may be associated with or give rise to invasive adenocarcinoma" and GED also represents a direct precursor of intestinal type adenocarcinoma of the stomach. The recommended treatment guidelines for GED in the medical literature are endoscopic mucosal resection (EMR) or surgery for high grade dysplasia (HGD) and annual endoscopic surveillance with biopsy for low grade dysplasia (LGD) The aim of this study was to determine the treatment plan for GED that is diagnosed by endoscopic biopsy. MATERIALS AND METHODS: We enrolled 148 patients who were treated by endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) for GED: there were 63 patients with HGD and 85 patients with LGD and all of them were diagnosed by endoscopic biopsy from January 2006 to December 2008. The results of the final histopathologic reports after EMR or ESD were compared with the results of the endoscopic biopsies. RESULTS: The final histopathologic results of the 148 patients with GED showed 49 (33.1%) patients with adenocarcinoma, 40 (27.0%) patients with HGD and 59 (39.9%) patients with LGD. Among the 63 patients with HGD, 34 (54.0%) patients had adenocarcinoma, 20 (31.7%) patients had HGD and 9 (14.3%) patients had LGD. For the 85 patients with LGD, 15 (17.6%) patients had adenocarcinoma, 20 (23.5%) patients had HGD and 50 (58.8%) patients had LGD. CONCLUSION: Complete resection, including EMR or ESD, is needed for patients with GED diagnosed by endoscopic biopsy and they have HGD. For patients with LGD, EMR or ESD may be needed in addition to endoscopic surveillance with biopsy for making the correct diagnosis and proper treatment because of the possibility of adenocarcinoma.
